Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.

The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.

Managed by an experienced team with decades of experience in the pharmaceutical and biotechnology sectors, the company is optimistic that development programs will continue at pace in the next 24 months.

Genflow Biosciences Executive Team

• Eric Leire, Founder and CEO

• Cedric Szpirer, Head of CMC

Genflow Biosciences Board Members

• Yassine Bendiabdallah, Chairman

• Eric Leire, Chief Executive Officer

• Guy Charles Fanneau de la Horie,  Non-executive director

• Peter King-Lewis, Non-executive director

• Tamara Joseph, Non-executive director

Genflow Biosciences Scientific Advisory Board

• Eric Verdin

• Vera Gorbunova

• Matthew Hirschey

• Manlio Vinciguerra